{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T21:28:11Z","timestamp":1758058091305,"version":"3.44.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008133","name":"Universidade de Pernambuco","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008133","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.ejphar.2013.03.038","type":"journal-article","created":{"date-parts":[[2013,4,6]],"date-time":"2013-04-06T02:30:46Z","timestamp":1365215446000},"page":"80-84","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Hypokalemia: A potent risk for QTc prolongation in clarithromycin treated rats"],"prefix":"10.1016","volume":"709","author":[{"given":"Sanmoy","family":"Karmakar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aswathi","family":"Padman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naga","family":"Swamy Mane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tuhinadri","family":"Sen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejphar.2013.03.038_bib1","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0022-0736(98)90006-1","article-title":"ECG changes during furosemide-induced hypokalemia in the rat","volume":"31","author":"Akita","year":"1998","journal-title":"J. Electrocardiol."},{"key":"10.1016\/j.ejphar.2013.03.038_bib2","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1128\/AAC.42.5.1176","article-title":"Steady-state pharmacokinetics and electrocardiographic pharmacodynamics of clarithromycin and loratadine after individual or concomitant administration","volume":"42","author":"Carr","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejphar.2013.03.038_bib3","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s002280100290","article-title":"Organising evidence on QT prolongation and occurrence of Torsades de Pointes with non-antiarrhythmic drugs: a call for consensus","volume":"57","author":"De Ponti","year":"2001","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2013.03.038_bib4","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1161\/01.HYP.35.5.1025","article-title":"Hypokalemia associated with diuretic use and cardiovascular events in the systolic hypertension in the elderly program","volume":"35","author":"Franse","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2013.03.038_bib5","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1161\/01.CIR.5.3.415","article-title":"Effect of potassium administration on (1) peripheral vascular reactivity and (2) blood pressure of the potassium deficient rats","volume":"5","author":"Friedman","year":"1952","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2013.03.038_bib6","unstructured":"Guidance for Industry-E14 Clinical Evaluation of QT\/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs. U.S. Department of Health and Human Services. Food and Drug Administration. Centre for Drug Evaluation and Research. October, 2005."},{"key":"10.1016\/j.ejphar.2013.03.038_bib7","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0378-5955(02)00448-3","article-title":"Evaluation of anesthesia effects in a rat animal model using otoacoustic emission protocols","volume":"170","author":"Hatzopoulos","year":"2002","journal-title":"Hear. Res."},{"key":"10.1016\/j.ejphar.2013.03.038_bib8","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0008-6363(00)00119-X","article-title":"The potential for QT prolongation and pro-arrhythmia by non-anti-arrhythmic drugs: clinical and regulatory implications: report on a Policy Conference of the European Society of Cardiology","volume":"47","author":"Haverkamp","year":"2000","journal-title":"Cardiovasc Res."},{"key":"10.1016\/j.ejphar.2013.03.038_bib9","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/1056-8719(94)90088-4","article-title":"Relationship between QT and RR intervals in rats, guinea pigs, rabbits, and primates","volume":"32","author":"Hayes","year":"1994","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.ejphar.2013.03.038_bib10","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0002-9343(86)90336-0","article-title":"Hypokalemia and arrhythmia","volume":"80","author":"Helfant","year":"1986","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ejphar.2013.03.038_bib11","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s11845-007-0057-3","article-title":"Clarithromycin induced torsade de pointes","volume":"7","author":"Hensey","year":"2008","journal-title":"Ir. J. Med. Sci."},{"key":"10.1016\/j.ejphar.2013.03.038_bib12","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ejphar.2010.05.038","article-title":"Heart rate correction of the QT duration in rats","volume":"641","author":"Kmecova","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2013.03.038_bib13","first-page":"145","article-title":"Bradycardia-related long QT syndrome and torsade de pointes: comparison between patients with complete AV block and with sinus bradycardia","volume":"35","author":"Kurita","year":"1994","journal-title":"Jpn. Heart J."},{"key":"10.1016\/j.ejphar.2013.03.038_bib14","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0002-9343(98)00059-X","article-title":"QT prolongation and Torsades de Pointes associated with clarithromycin","volume":"104","author":"Lee","year":"1998","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ejphar.2013.03.038_bib15","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1128\/AAC.46.3.938-939.2002","article-title":"Importance of Species Selection in Arrythmogenic Models of Q-T interval prolongation","volume":"46","author":"McDermott","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejphar.2013.03.038_bib16","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1124\/jpet.102.037911","article-title":"Divergent proarrhythmic potential of macrolide antibiotics despite similar QT prolongation: fast phase 3 repolarisation prevents early afterdepolarisations and torsade de pointes","volume":"303","author":"Milberg","year":"2002","journal-title":"J. Pharmacol. Exp Ther."},{"key":"10.1016\/j.ejphar.2013.03.038_bib17","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1128\/AAC.44.10.2630-2637.2000","article-title":"Comparative pharmacodynamic analysis of Q-T interval prolongation induced by the macrolides clarithromycin, roxithromycin and azithromycin in rats","volume":"44","author":"Ohtani","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejphar.2013.03.038_bib18","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1136\/pgmj.77.914.759","article-title":"Hypokalaemia and hyperkalaemia","volume":"77","author":"Rastergar","year":"2001","journal-title":"Postgrad. Med. J."},{"key":"10.1016\/j.ejphar.2013.03.038_bib19","first-page":"1881","volume":"366","author":"Ray","year":"2012","journal-title":"Azithromycin and the risk of cardiovascular death"},{"key":"10.1016\/j.ejphar.2013.03.038_bib20","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1056\/NEJMoa040582","article-title":"Oral erythromycin and the risk of sudden death from cardiac causes","volume":"351","author":"Ray","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2013.03.038_bib21","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1111\/j.1540-8159.1991.tb02841.x","article-title":"Bradycardia-dependent early afterdepolarizations in a patient with QTU prolongation and torsade de pointes in association with marked bradycardia and hypokalemia","volume":"14","author":"Shimizu","year":"1991","journal-title":"Pacing Clin. Electrophysiol."},{"key":"10.1016\/j.ejphar.2013.03.038_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/A:1027309703313","article-title":"Characterization of the inhibitory effects of erythromycin and clarithromycin in the HERG potassium channel","volume":"254","author":"Stanat","year":"2003","journal-title":"Mol. Cell Biochem."},{"key":"10.1016\/j.ejphar.2013.03.038_bib23","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1124\/jpet.302.1.320","article-title":"Blockade of human cardiac potassium channel human ether-a-go-go-related gene (HERG) by macrolide antibiotics","volume":"302","author":"Volberg","year":"2002","journal-title":"J. Pharmacol Exp. Ther."},{"key":"10.1016\/j.ejphar.2013.03.038_bib24","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1213\/00000539-199312000-00027","article-title":"Hypokalemia and anaesthetic implications","volume":"77","author":"Wong","year":"1993","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.ejphar.2013.03.038_bib25","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1161\/01.RES.80.2.261","article-title":"Tissue and species distribution of mRNA for the ikr-like K+ channel, ERG","volume":"80","author":"Wymore","year":"1997","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2013.03.038_bib26","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1161\/01.CIR.93.3.407","article-title":"Extracellular potassium modulation of drug block of IKr. Implications for torsade de pointes and reverse use-dependence","volume":"93","author":"Yang","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2013.03.038_bib27","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1136\/heart.89.11.1363","article-title":"Drug induced QT prolongation and torsades de pointes","volume":"89","author":"Yap","year":"2003","journal-title":"Heart"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299913002562?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299913002562?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:17:26Z","timestamp":1757974646000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299913002562"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":27,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S0014299913002562"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2013.03.038","relation":{},"ISSN":["0014-2999"],"issn-type":[{"type":"print","value":"0014-2999"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypokalemia: A potent risk for QTc prolongation in clarithromycin treated rats","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2013.03.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}